The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Pregabalin-Global Market Insights and Sales Trends 2025

Pregabalin-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1815438

No of Pages : 124

Ask Your Query
Synopsis
Pregabalin is an anticonvulsant drug used for the treatment of epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its mode of action involves decrease in pain signals sent by the damaged nerves in the body.
The global Pregabalin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pregabalin in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Pregabalin market. Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Capsule segment is estimated at % CAGR for the next seven-year period.
Increase in geriatric population suffering from neuropathic diabetes and rise in prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders are expected to drive the Pregabalin market. 
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pregabalin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pregabalin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pregabalin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pregabalin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pregabalin covered in this report include ZCL Chemicals, Olon S.p.A., AASraw Biochemical Technology, Changzhou Pharmaceutical Factory (CPF), Almelo Pvt. Ltd., Divi’s Laboratories, Angels Pharma, ARITE Pharmaceutical and BAL Pharma, etc.
The global Pregabalin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
ZCL Chemicals
Olon S.p.A.
AASraw Biochemical Technology
Changzhou Pharmaceutical Factory (CPF)
Almelo Pvt. Ltd.
Divi’s Laboratories
Angels Pharma
ARITE Pharmaceutical
BAL Pharma
Bazayan
Aurobindo Pharma
Hikal
Glenmark Life Sciences
Dongbang FTL
Teva Pharmaceutical Industries
Divi’s Laboratories
Chemo Iberica
Maps Laboratories
Laurus Labs
Zhejiang Huahai Pharmaceutical
Vasudha Pharma Chem
Sun Pharmaceutical Industries
CTX Life Sciences
Srini Pharmaceuticals
Global Pregabalin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pregabalin market, Segment by Type:
Tablet
Capsule
Oral Solution
Global Pregabalin market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Pregabalin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Pregabalin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Pregabalin Market Overview
1.1 Pregabalin Product Overview
1.2 Pregabalin Market Segment by Type
1.2.1 Tablet
1.2.2 Capsule
1.2.3 Oral Solution
1.3 Global Pregabalin Market Size by Type
1.3.1 Global Pregabalin Market Size Overview by Type (2018-2029)
1.3.2 Global Pregabalin Historic Market Size Review by Type (2018-2023)
1.3.3 Global Pregabalin Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pregabalin Sales Breakdown by Type (2018-2023)
1.4.2 Europe Pregabalin Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Pregabalin Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Pregabalin Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Pregabalin Sales Breakdown by Type (2018-2023)
2 Global Pregabalin Market Competition by Company
2.1 Global Top Players by Pregabalin Sales (2018-2023)
2.2 Global Top Players by Pregabalin Revenue (2018-2023)
2.3 Global Top Players by Pregabalin Price (2018-2023)
2.4 Global Top Manufacturers Pregabalin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pregabalin Market Competitive Situation and Trends
2.5.1 Pregabalin Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Pregabalin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pregabalin as of 2022)
2.7 Date of Key Manufacturers Enter into Pregabalin Market
2.8 Key Manufacturers Pregabalin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pregabalin Status and Outlook by Region
3.1 Global Pregabalin Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Pregabalin Historic Market Size by Region
3.2.1 Global Pregabalin Sales in Volume by Region (2018-2023)
3.2.2 Global Pregabalin Sales in Value by Region (2018-2023)
3.2.3 Global Pregabalin Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Pregabalin Forecasted Market Size by Region
3.3.1 Global Pregabalin Sales in Volume by Region (2024-2029)
3.3.2 Global Pregabalin Sales in Value by Region (2024-2029)
3.3.3 Global Pregabalin Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Pregabalin by Application
4.1 Pregabalin Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Pregabalin Market Size by Application
4.2.1 Global Pregabalin Market Size Overview by Application (2018-2029)
4.2.2 Global Pregabalin Historic Market Size Review by Application (2018-2023)
4.2.3 Global Pregabalin Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pregabalin Sales Breakdown by Application (2018-2023)
4.3.2 Europe Pregabalin Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Pregabalin Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Pregabalin Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Pregabalin Sales Breakdown by Application (2018-2023)
5 North America Pregabalin by Country
5.1 North America Pregabalin Historic Market Size by Country
5.1.1 North America Pregabalin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Pregabalin Sales in Volume by Country (2018-2023)
5.1.3 North America Pregabalin Sales in Value by Country (2018-2023)
5.2 North America Pregabalin Forecasted Market Size by Country
5.2.1 North America Pregabalin Sales in Volume by Country (2024-2029)
5.2.2 North America Pregabalin Sales in Value by Country (2024-2029)
6 Europe Pregabalin by Country
6.1 Europe Pregabalin Historic Market Size by Country
6.1.1 Europe Pregabalin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Pregabalin Sales in Volume by Country (2018-2023)
6.1.3 Europe Pregabalin Sales in Value by Country (2018-2023)
6.2 Europe Pregabalin Forecasted Market Size by Country
6.2.1 Europe Pregabalin Sales in Volume by Country (2024-2029)
6.2.2 Europe Pregabalin Sales in Value by Country (2024-2029)
7 Asia-Pacific Pregabalin by Region
7.1 Asia-Pacific Pregabalin Historic Market Size by Region
7.1.1 Asia-Pacific Pregabalin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Pregabalin Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Pregabalin Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Pregabalin Forecasted Market Size by Region
7.2.1 Asia-Pacific Pregabalin Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Pregabalin Sales in Value by Region (2024-2029)
8 Latin America Pregabalin by Country
8.1 Latin America Pregabalin Historic Market Size by Country
8.1.1 Latin America Pregabalin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Pregabalin Sales in Volume by Country (2018-2023)
8.1.3 Latin America Pregabalin Sales in Value by Country (2018-2023)
8.2 Latin America Pregabalin Forecasted Market Size by Country
8.2.1 Latin America Pregabalin Sales in Volume by Country (2024-2029)
8.2.2 Latin America Pregabalin Sales in Value by Country (2024-2029)
9 Middle East and Africa Pregabalin by Country
9.1 Middle East and Africa Pregabalin Historic Market Size by Country
9.1.1 Middle East and Africa Pregabalin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Pregabalin Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Pregabalin Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Pregabalin Forecasted Market Size by Country
9.2.1 Middle East and Africa Pregabalin Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Pregabalin Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 ZCL Chemicals
10.1.1 ZCL Chemicals Company Information
10.1.2 ZCL Chemicals Introduction and Business Overview
10.1.3 ZCL Chemicals Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.1.4 ZCL Chemicals Pregabalin Products Offered
10.1.5 ZCL Chemicals Recent Development
10.2 Olon S.p.A.
10.2.1 Olon S.p.A. Company Information
10.2.2 Olon S.p.A. Introduction and Business Overview
10.2.3 Olon S.p.A. Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Olon S.p.A. Pregabalin Products Offered
10.2.5 Olon S.p.A. Recent Development
10.3 AASraw Biochemical Technology
10.3.1 AASraw Biochemical Technology Company Information
10.3.2 AASraw Biochemical Technology Introduction and Business Overview
10.3.3 AASraw Biochemical Technology Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.3.4 AASraw Biochemical Technology Pregabalin Products Offered
10.3.5 AASraw Biochemical Technology Recent Development
10.4 Changzhou Pharmaceutical Factory (CPF)
10.4.1 Changzhou Pharmaceutical Factory (CPF) Company Information
10.4.2 Changzhou Pharmaceutical Factory (CPF) Introduction and Business Overview
10.4.3 Changzhou Pharmaceutical Factory (CPF) Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Changzhou Pharmaceutical Factory (CPF) Pregabalin Products Offered
10.4.5 Changzhou Pharmaceutical Factory (CPF) Recent Development
10.5 Almelo Pvt. Ltd.
10.5.1 Almelo Pvt. Ltd. Company Information
10.5.2 Almelo Pvt. Ltd. Introduction and Business Overview
10.5.3 Almelo Pvt. Ltd. Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Almelo Pvt. Ltd. Pregabalin Products Offered
10.5.5 Almelo Pvt. Ltd. Recent Development
10.6 Divi’s Laboratories
10.6.1 Divi’s Laboratories Company Information
10.6.2 Divi’s Laboratories Introduction and Business Overview
10.6.3 Divi’s Laboratories Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Divi’s Laboratories Pregabalin Products Offered
10.6.5 Divi’s Laboratories Recent Development
10.7 Angels Pharma
10.7.1 Angels Pharma Company Information
10.7.2 Angels Pharma Introduction and Business Overview
10.7.3 Angels Pharma Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Angels Pharma Pregabalin Products Offered
10.7.5 Angels Pharma Recent Development
10.8 ARITE Pharmaceutical
10.8.1 ARITE Pharmaceutical Company Information
10.8.2 ARITE Pharmaceutical Introduction and Business Overview
10.8.3 ARITE Pharmaceutical Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.8.4 ARITE Pharmaceutical Pregabalin Products Offered
10.8.5 ARITE Pharmaceutical Recent Development
10.9 BAL Pharma
10.9.1 BAL Pharma Company Information
10.9.2 BAL Pharma Introduction and Business Overview
10.9.3 BAL Pharma Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.9.4 BAL Pharma Pregabalin Products Offered
10.9.5 BAL Pharma Recent Development
10.10 Bazayan
10.10.1 Bazayan Company Information
10.10.2 Bazayan Introduction and Business Overview
10.10.3 Bazayan Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Bazayan Pregabalin Products Offered
10.10.5 Bazayan Recent Development
10.11 Aurobindo Pharma
10.11.1 Aurobindo Pharma Company Information
10.11.2 Aurobindo Pharma Introduction and Business Overview
10.11.3 Aurobindo Pharma Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Aurobindo Pharma Pregabalin Products Offered
10.11.5 Aurobindo Pharma Recent Development
10.12 Hikal
10.12.1 Hikal Company Information
10.12.2 Hikal Introduction and Business Overview
10.12.3 Hikal Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Hikal Pregabalin Products Offered
10.12.5 Hikal Recent Development
10.13 Glenmark Life Sciences
10.13.1 Glenmark Life Sciences Company Information
10.13.2 Glenmark Life Sciences Introduction and Business Overview
10.13.3 Glenmark Life Sciences Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Glenmark Life Sciences Pregabalin Products Offered
10.13.5 Glenmark Life Sciences Recent Development
10.14 Dongbang FTL
10.14.1 Dongbang FTL Company Information
10.14.2 Dongbang FTL Introduction and Business Overview
10.14.3 Dongbang FTL Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Dongbang FTL Pregabalin Products Offered
10.14.5 Dongbang FTL Recent Development
10.15 Teva Pharmaceutical Industries
10.15.1 Teva Pharmaceutical Industries Company Information
10.15.2 Teva Pharmaceutical Industries Introduction and Business Overview
10.15.3 Teva Pharmaceutical Industries Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Teva Pharmaceutical Industries Pregabalin Products Offered
10.15.5 Teva Pharmaceutical Industries Recent Development
10.16 Divi’s Laboratories
10.16.1 Divi’s Laboratories Company Information
10.16.2 Divi’s Laboratories Introduction and Business Overview
10.16.3 Divi’s Laboratories Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Divi’s Laboratories Pregabalin Products Offered
10.16.5 Divi’s Laboratories Recent Development
10.17 Chemo Iberica
10.17.1 Chemo Iberica Company Information
10.17.2 Chemo Iberica Introduction and Business Overview
10.17.3 Chemo Iberica Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Chemo Iberica Pregabalin Products Offered
10.17.5 Chemo Iberica Recent Development
10.18 Maps Laboratories
10.18.1 Maps Laboratories Company Information
10.18.2 Maps Laboratories Introduction and Business Overview
10.18.3 Maps Laboratories Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Maps Laboratories Pregabalin Products Offered
10.18.5 Maps Laboratories Recent Development
10.19 Laurus Labs
10.19.1 Laurus Labs Company Information
10.19.2 Laurus Labs Introduction and Business Overview
10.19.3 Laurus Labs Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Laurus Labs Pregabalin Products Offered
10.19.5 Laurus Labs Recent Development
10.20 Zhejiang Huahai Pharmaceutical
10.20.1 Zhejiang Huahai Pharmaceutical Company Information
10.20.2 Zhejiang Huahai Pharmaceutical Introduction and Business Overview
10.20.3 Zhejiang Huahai Pharmaceutical Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Zhejiang Huahai Pharmaceutical Pregabalin Products Offered
10.20.5 Zhejiang Huahai Pharmaceutical Recent Development
10.21 Vasudha Pharma Chem
10.21.1 Vasudha Pharma Chem Company Information
10.21.2 Vasudha Pharma Chem Introduction and Business Overview
10.21.3 Vasudha Pharma Chem Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.21.4 Vasudha Pharma Chem Pregabalin Products Offered
10.21.5 Vasudha Pharma Chem Recent Development
10.22 Sun Pharmaceutical Industries
10.22.1 Sun Pharmaceutical Industries Company Information
10.22.2 Sun Pharmaceutical Industries Introduction and Business Overview
10.22.3 Sun Pharmaceutical Industries Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.22.4 Sun Pharmaceutical Industries Pregabalin Products Offered
10.22.5 Sun Pharmaceutical Industries Recent Development
10.23 CTX Life Sciences
10.23.1 CTX Life Sciences Company Information
10.23.2 CTX Life Sciences Introduction and Business Overview
10.23.3 CTX Life Sciences Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.23.4 CTX Life Sciences Pregabalin Products Offered
10.23.5 CTX Life Sciences Recent Development
10.24 Srini Pharmaceuticals
10.24.1 Srini Pharmaceuticals Company Information
10.24.2 Srini Pharmaceuticals Introduction and Business Overview
10.24.3 Srini Pharmaceuticals Pregabalin Sales, Revenue and Gross Margin (2018-2023)
10.24.4 Srini Pharmaceuticals Pregabalin Products Offered
10.24.5 Srini Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pregabalin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pregabalin Industrial Chain Analysis
11.4 Pregabalin Market Dynamics
11.4.1 Pregabalin Industry Trends
11.4.2 Pregabalin Market Drivers
11.4.3 Pregabalin Market Challenges
11.4.4 Pregabalin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pregabalin Distributors
12.3 Pregabalin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock